SanaHeal key facts
as of Oct 2026- Developer of bioadhesive medical technologies designed to achieve rapid and strong adhesion to wet and irregular tissue surfaces.
- SanaHeal is valued at approximately $22.5M as of Oct 2026 (last reported valuation).
- It has raised $14.3M; the latest was Later Stage VC ($10.5M) in Dec 2024.
- Notable investors include Creative Destruction Lab, MedTech Innovator, University of Toronto, University of Toronto Entrepreneurship, SBXi — 17 tracked in total.
- Status: Privately Held (backing).
SanaHeal's last reported valuation, Dec 2024. Nothing priced has surfaced since.
- ·The complete investor list: 17 names
- ·Watch SanaHeal: the Monday email on marks, rounds and moves
SanaHeal funding rounds
No funding rounds for SanaHeal are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
Who backs SanaHeal
17+SanaHeal valuation
SanaHeal's last reported valuation was $22.5 million in Dec 2024. No priced round, secondary trade or fund mark has surfaced since.
SanaHeal investors
17 investors are on record for SanaHeal, including Creative Destruction Lab, MedTech Innovator, University of Toronto and University of Toronto Entrepreneurship.
About SanaHeal
Developer of bioadhesive medical technologies designed to achieve rapid and strong adhesion to wet and irregular tissue surfaces. The company offers nature-inspired adhesives modeled after barnacles and spider webs that clean and bond to uneven or contaminated areas, provide instant drying and secure attachment in moist environments, and undergo pre-clinical testing, enabling healthcare providers and medical device manufacturers to improve wound closure and tissue repair with materials that adhere effectively in challenging biological conditions.
- Sector
- Healthcare
- HQ
- Somerville, MA, United States
- Founded
- 2020
- Employees
- 8
- Website
- sanaheal.com/
- Ownership
- Privately Held (backing)
Is this your company? Sign in with your work email to keep it current, or tell us what's wrong.